Close Menu

Van Andel Research Institute

In Nature this week: increased epigenetic upregulation of TET2 in Parkinson's disease, and more.

In Genome Biology this week: difference in methylation in neurons from Parkinson's disease patients, differential expression analysis by barcoded sequencing approach, and more.

The researchers found that both a SNP and prenatal factors like maternal age influence imprinting at the nc886 gene.

Using peptide arrays, researchers identified a number of protein methylation sites and found that such sites are likely underrepresented in mass spec datasets.

In Nucleic Acids Research this week: chromatin accessibility profiles in P. falciparum during development, transcriptional start sites and regulatory patterns in A. baumannii, and more.

The centers will support the NCI's Genomic Data Analysis Network, which is tasked with creating tools and strategies to study large-scale genomics data.

NEW YORK (GenomeWeb) – A research team headed by scientists at the Van Andel Research Institute and the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University will receive $7.5 million in funding for a three-year period from VARI to continue epigenetics research into cancer, the in

NEW YORK (GenomeWeb News) – The Van Andel Institute plans to become a hub of epigenetics research by developing a consortium of four US academic institutions and one from abroad that will collaborate to develop new personalized epigenetic treatments.

NEW YORK (GenomeWeb News) – The Van Andel Institute has received a $500,000 award to launch an effort that will use genomic data to develop new personalized treatment options for a rare genetic disorder.

The story has been updated to include comments from a conference call.
NEW YORK (GenomeWeb News) – Agilent Technologies and Swedish private equity firm EQT today announced that Agilent will acquire cancer diagnostics firm Dako from EQT for $2.2 billion.

Pages

President Donald Trump might not approve the stricter standards the US Food and Drug Administration is developing for authorizing a SARS-CoV-2 vaccine, according to Politico.

Wired reports that Oxitec has now developed a genetically modified fall armyworm.

A large genetic study finds SARS-CoV-2 viruses with a certain variant are spreading more than others, according to the Washington Post.

In Nature this week: sister-chromatid-sensitive chromosome conformation capture approach, and more.